|


This content has been retired.
For more information about our programs, please click on one of the links below.
|
© 2006-2022 Global Solutions for Infectious Diseases, All Rights Reserved |

Enrollment of volunteers into the PrEPVacc Phase IIb clinical efficacy trial is underway at sites located in Uganda, Tanzania and South Africa.
[more]
|
 |